Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Sprains and Strains 1Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Febrile Neutropenia 1

Interventions

Vincristine 4Radiotherapy 3Procarbazine 3Methotrexate 3Cytarabine 3Rituximab 2Prednisolone 2Cyclophosphamide 2motexafin gadolinium 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1Simvastatin 1Neuropsychological Tests 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin 1 Receptor Antagonist Protein 1Glutamine 1Glutamic Acid 1Etoposide 1Doxorubicin 1Dietary Supplements 1Dexamethasone 1Contrast Media 1Bendamustine Hydrochloride 1Baclofen 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Simvastatin × Lymphoid × Clear all
NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Active not recruiting
37 enrolled
Lymphoid

Lymphoma, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡